Didem Sanver, PhD, Associate Editor, Springer Nature, UK
Didem joined the BMC series in August 2022. She holds an MSc in Bionanotechnology from the University of Sheffield and completed her PhD with an award of Research Excellence in a joint project between Food Science, Nutrition and Chemistry departments from the University of Leeds. Coming from a multidisciplinary research background in life sciences, she also worked as a postdoctoral researcher in the Clinical Allergy and Immunology department at Imperial College London. She is passionate about serving the scientific community as an editor and supports openness and transparency in research publishing. Didem is based at the London office.
Senior Editorial Board Members
Prof Srikanth Bellary, Aston University, UK
Dr Bellary is a Reader in Metabolic Medicine at the Aston University and an Honorary Consultant Physician in Diabetes and Endocrinology at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. He graduated from Osmania University, India and subsequently completed higher specialist training in Diabetes Endocrinology in the United Kingdom. He was awarded the MD Degree in Medicine by the University of Birmingham, UK for his research in type 2 diabetes in south Asians. His clinical interests include obesity and diabetic kidney disease and has been instrumental in developing new care models for diabetes. His research interests include epidemiology of type 2 diabetes, diabetic kidney disease, new therapies for diabetes and metabolic ageing. He was one of the lead investigators of the UK Asian Diabetes Study. He is the Chief Investigator for Type 2 diabetes in Youth (T2DMY) Study and UK Chief Investigator for the Semaglutide and Renal Outcomes (FLOW) study besides being a Principal Investigator for several type 2 diabetes studies. He has published over a hundred papers in several reputed journals. Dr Bellary is a senior editor for BMC Endocrine Disorders and an Associate Editor for Therapeutic advances in Diabetes and Endocrinology. He is also the chair of Pan Birmingham Diabetes Network and works closely with Diabetes UK. He was one of the 12 National Diabetes UK clinical champions in 2014.
Dr Flávio Cadegiani, MD Corpometria Institute, Brazil
Flávio Cadegiani is a board certified endocrinologist with Ph.D. in Clinical Endocrinology. His areas of expertise include adrenal disorders, obesity, endocrinology of physical activity and fatigue-related conditions. He focused his studies on fatigue-related conditions, in particular a systematic review in which he debunked the existence of a pseudo-disease termed as 'adrenal fatigue', and conducted one of the largest studies on Sports Endocrinology, named 'Endocrine and Metabolic Responses on Overtraining Syndrome (EROS) Study'. His book: 'Overtraining Syndrome in Athletes - A Comprehensive Review and New Perspectives') was recently published by Springer Nature. Currently, he is CEO and Medical Director of Corpometria Institute (Brasilia, Brazil), that together with Applied Biology Inc (Irvine, CA, USA) has lead the research on the roles of androgens and anti-androgen agents on COVID-19. He is also a regular visiting professor in FAESF (Floriano, Brazil).
Prof Nadia Sawicka-Gutaj, Poznan University, Poland
I am the Associate Professor in the Department of Endocrinology, Metabolism and Internal Medicine at the Poznan Univeristy of Medical Sciences in Poland. I graduated cum laude from Medical Faculty in Poznan University of Medical Sciences in 2010. I am an internal medicine specialist and endocrinologist. I am also the Associate Dean for Clinical Courses of Medicine Program and Coordinator of Internal Medicine Course and Endocrinology Course for English-speaking students. I am a co-author of app. 65 articles and app. 40 conference abstracts. My H-index is 10 and IF app. 150. In 2016-2021 I was a member of Executive Committee of Polish Society of Endocrinology and a chair of Young Polish Endocrinologists. My main scientific interests are related to thyroid dysfunction, thyroid cancers, pituitary disorders, Graves’ orbitopathy, hypogonadism, health-related quality of life.